Ferhan Qureshi
Senior Vice President, Biomarker R&D
@
Octave
About Ferhan Qureshi
Ferhan Qureshi is the Senior Vice President of Biomarker R&D, known for his work on serum protein biomarkers for Optic Neuritis in multiple sclerosis patients.
Known information
Ferhan Qureshi serves as the Senior Vice President of Biomarker Research and Development. He has made significant contributions to the field of neurology, particularly through his research on Optic Neuritis, a condition often associated with multiple sclerosis. Qureshi’s work focuses on the predictive utility of serum protein biomarkers to forecast Optic Neuritis events. His findings were prominently presented at the 2024 Annual Meeting of the American Academy of Neurology (AAN), highlighting their potential impact on the management and treatment of multiple sclerosis.
About Octave
Octave is a healthcare company specializing in the treatment and management of multiple sclerosis (MS) through integrated biological, imaging, and clinical insights.